Corporate Officers
Henri A. Termeer
Chairman of the Board; President; Chief Executive Officer
Jason A. Amello
Corporate Controller; Chief Accounting Officer
John P. Butler
Senior Vice President; President, Personalized Genetic Health
Scott Canute
Executive Vice President; President, Global Manufacturing and Corporate Operations
Zoltan Csimma
Senior Vice President; Chief Human Resources Officer
Thomas J. DesRosier, Esquire
Senior Vice President; General Counsel; Chief Legal Officer
Richard H. Douglas, Ph.D.
Senior Vice President, Corporate Development
Mark J. Enyedy
Senior Vice President; President, Genetics, Transplant, Oncology & Multiple Sclerosis
David D. Fleming
Group Senior Vice President
James A. Geraghty
Senior Vice President
Carlo Incerti
Senior Vice President, Global Market Access
Alison Lawton
Senior Vice President; General Manager, Biosurgery
Roger W. Louis, Esquire
Chief Compliance Officer
Mary McGrane
Vice President; Senior Vice President, Government Relations
John M. McPherson, Ph.D.
Senior Vice President, Biologics Research and Development
David Meeker, M.D.
Chief Operating Officer
C. Ann Merrifield
Senior Vice President, Business Excellence Initiative
Richard A. Moscicki, M.D.
Senior Vice President, Clinical Development and Medical Affairs; Chief Medical Officer
Donald E. Pogorzelski
Vice President; President, Diagnostic Products
Alan E. Smith, Ph.D.
Senior Vice President, Research; Chief Scientific Officer
Sandford D. Smith
Executive Vice President; President, International Group
Gail F. Sullivan
Treasurer
Peter Wirth, Esquire
Executive Vice President, Legal and Corporate Development; Secretary
Michael S. Wyzga
Executive Vice President, Finance; Chief Financial Officer
|
Home
